In the vast and rural expanse of Northern British Columbia, a new chemical shadow has entered the unregulated drug supply — cychlorphine, a synthetic opioid estimated to be ten times more potent than fentanyl, discovered in pills sold as ordinary prescription medication. Health authorities issued an urgent alert on Friday, August 14, 2026, not merely as a warning about one substance, but as a reminder of how profoundly the invisible architecture of unregulated markets can betray those who depend on them. The danger is not only pharmacological; it is structural — a consequence of supply chains
Potent synthetic opioid cychlorphine detected in counterfeit Dilaudid across Northern B.C.
Overdose risk significantly elevated for people using unregulated drugs in Northern B.C., particularly those consuming counterfeit opioid pills.